Singapore markets closed
Straits Times Index
3,309.21 -12.87 (-0.39%) S&P 500
5,360.79 +13.80 (+0.26%) Dow
38,868.04 +69.05 (+0.18%) Nasdaq
17,192.53 +59.40 (+0.35%) Bitcoin USD
66,886.33 -2,397.91 (-3.46%) CMC Crypto 200
1,392.57 -49.07 (-3.40%)
Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ)
Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
At close: 03:04PM CST
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 2.89B |
| Enterprise value | 2.66B |
| Trailing P/E | 53.76 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.60 |
| Price/book (mrq) | 1.34 |
| Enterprise value/revenue | 2.44 |
| Enterprise value/EBITDA | 32.71 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.41 |
| 52-week change 3 | -29.37% |
| S&P500 52-week change 3 | 22.70% |
| 52-week high 3 | 15.49 |
| 52-week low 3 | 6.74 |
| 50-day moving average 3 | 10.35 |
| 200-day moving average 3 | 11.90 |
Share statistics
| Avg vol (3-month) 3 | 9.15M |
| Avg vol (10-day) 3 | 11.17M |
| Shares outstanding 5 | 316.39M |
| Implied shares outstanding 6 | 316.39M |
| Float 8 | 99M |
| % held by insiders 1 | 66.55% |
| % held by institutions 1 | 1.57% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.2 |
| Forward annual dividend yield 4 | 2.19% |
| Trailing annual dividend rate 3 | 0.20 |
| Trailing annual dividend yield 3 | 2.19% |
| 5-year average dividend yield 4 | 2.33 |
| Payout ratio 4 | 58.82% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 05 Jun 2024 |
| Last split factor 2 | 1.5:1 |
| Last split date 3 | 13 Jun 2018 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 4.88% |
| Operating margin (ttm) | -2.76% |
Management effectiveness
| Return on assets (ttm) | -0.68% |
| Return on equity (ttm) | 2.31% |
Income statement
| Revenue (ttm) | 1.09B |
| Revenue per share (ttm) | 3.52 |
| Quarterly revenue growth (yoy) | -27.90% |
| Gross profit (ttm) | N/A |
| EBITDA | 60.24M |
| Net income avi to common (ttm) | 53.29M |
| Diluted EPS (ttm) | 0.17 |
| Quarterly earnings growth (yoy) | -52.00% |
Balance sheet
| Total cash (mrq) | 1.16B |
| Total cash per share (mrq) | 3.69 |
| Total debt (mrq) | 925.95M |
| Total debt/equity (mrq) | 42.71% |
| Current ratio (mrq) | 1.36 |
| Book value per share (mrq) | 6.90 |
Cash flow statement
| Operating cash flow (ttm) | -26.28M |
| Levered free cash flow (ttm) | -299.61M |
© 2024 Yahoo. All rights reserved.